share_log

HCA Healthcare | 10-Q: Q3 2024 Earnings Report

SEC ·  Nov 1, 2024 04:36

Summary by Futu AI

HCA Healthcare reported strong financial results for Q3 2024, with revenues increasing 7.9% to $17.49 billion from $16.21 billion in Q3 2023. Net income attributable to HCA rose 17.7% to $1.27 billion, or $4.88 per diluted share, compared to $1.08 billion, or $3.91 per diluted share, in the prior year period. The growth was driven by a 5.0% increase in equivalent admissions and a 2.8% increase in revenue per equivalent admission.Same facility metrics showed solid performance with admissions up 4.5% and emergency department visits increasing 4.6% year-over-year. The company achieved operational improvements with salaries and benefits as a percentage of revenues decreasing to 45.0% from 46.6% last year, benefiting from a 17.8% reduction in contract labor costs. Supply costs increased to 15.2% of revenues compared to 14.9% in Q3 2023.Looking ahead, HCA expects additional expenses of $200-300 million in Q4 2024 due to impacts from Hurricanes Helene and Milton on facilities in Florida and North Carolina. The company maintains a strong financial position with $7.99 billion available under credit facilities and plans approximately $5 billion in capital expenditures for 2024. During Q3, HCA repurchased 4.95 million shares at an average price of $362.74 per share.
HCA Healthcare reported strong financial results for Q3 2024, with revenues increasing 7.9% to $17.49 billion from $16.21 billion in Q3 2023. Net income attributable to HCA rose 17.7% to $1.27 billion, or $4.88 per diluted share, compared to $1.08 billion, or $3.91 per diluted share, in the prior year period. The growth was driven by a 5.0% increase in equivalent admissions and a 2.8% increase in revenue per equivalent admission.Same facility metrics showed solid performance with admissions up 4.5% and emergency department visits increasing 4.6% year-over-year. The company achieved operational improvements with salaries and benefits as a percentage of revenues decreasing to 45.0% from 46.6% last year, benefiting from a 17.8% reduction in contract labor costs. Supply costs increased to 15.2% of revenues compared to 14.9% in Q3 2023.Looking ahead, HCA expects additional expenses of $200-300 million in Q4 2024 due to impacts from Hurricanes Helene and Milton on facilities in Florida and North Carolina. The company maintains a strong financial position with $7.99 billion available under credit facilities and plans approximately $5 billion in capital expenditures for 2024. During Q3, HCA repurchased 4.95 million shares at an average price of $362.74 per share.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.